Mehmet Kucukosmanoglu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mehmet Kucukosmanoglu has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Arafat Yildirim
Department of Cardiology, Adana Training and Research Hospital, University of Health Sciences, Adana, Turkey
1 shared publication - Emre Akkaya
Department of Cardiology, Gaziantep State Hospital, Gaziantep, Turkey
1 shared publication - Fadime Koca
Department of Cardiology Cukurova State Hospital Adana Turkey
1 shared publication - Hilmi Erdem Sumbul
Department of Internal Medicine, University of Health Sciences, Adana Health Practice and Research Center, Adana 01230, Türkiye
1 shared publication - Idris Ardic
Department of Cardiology, Medicine Faculty of Erciyes University, Kayseri, Turkey
1 shared publication - Isa Sincer
Department of Cardiology, Faculty of Medicine, Abant İzzet Baysal University, Bolu, Türkiye
1 shared publication
Latest Publications
- Open Access
- 14 April 2026
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 13 (4) , 167
The Frontal QRS-T Angle Remains Unchanged in Patients Without Structural Heart Disease Receiving Flecainide Therapy
Introduction: Prolongation of the QT interval and QRS duration, which are markers of ventricular repolarization and depolarization, has been reported in patients receiving flecainide therapy. However, the effects of flecainide on the QRS–T angle—a recognized indicator of transmural dispersion of repolarization—remain unclear. The aim of our study was to investigate the impact of flecainide therapy on the QRS–T angle. Method: In this study, 200 patients who were prescribed flecainide therapy due to atrial or ventricular arrhythmias were included. Prior to the initiation of flecainide treatment, all patients underwent a 12-lead electrocardiogram (ECG) in which heart rate (HR), PR and QRS durations, QT, QTc, JT, Tp–Te intervals and the frontal plane QRS–T angle were measured. At the 1-month follow-up, patients underwent repeat ECG recording and were evaluated for both cardiac and non-cardiac side effects of flecainide. The same ECG parameters were measured again using the follow-up recordings. Changes in ECG parameters between the baseline and 1-month post-treatment were analyzed. Results: Following flecainide administration, the drug was discontinued in 18 patients (9%) due to adverse effects (11 cases of cardiac and seven cases of non-cardiac). HR significantly decreased (78 ± 22 bpm to 74 ± 15 bpm and p < 0.05). PR interval and QRS duration significantly increased (148 ± 23 ms to 156 ± 9 ms and 89 ± 17 ms to 99 ± 19 ms, respectively p < 0.05 for each). Additionally, JT interval (326 ± 27 ms vs. 334 ± 6 ms), QT interval (416 ± 24 ms vs. 434 ± 24 ms), QTc interval (431 ± 24 vs. 447 ± 25 ms) and Tp–Te interval (84 ± 17 vs. 87 ± 18 ms) all showed statistically significant increases after flecainide treatment (p < 0.05 for-each). However, no significant change was observed in the frontal QRS–T angle. Discussion: In patients receiving flecainide therapy for atrial and ventricular arrhythmias, prolongation was observed in atrioventricular conduction, ventricular depolarization and repolarization parameters as measured by ECG. However, no significant change was detected in the frontal QRS–T angle.
- 14 April 2026
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 13 (4) , 167
Open AccessThe Frontal QRS-T Angle Remains Unchanged in Patients Without Structural Heart Disease Receiving Flecainide Therapy
Introduction: Prolongation of the QT interval and QRS duration, which are markers of ventricular repolarization and depolarization, has been reported in patients receiving flecainide therapy. However, the effects of flecainide on the QRS–T angle—a recognized indicator of transmural dispersion of repolarization—remain unclear. The aim of our study was to investigate the impact of flecainide therapy on the QRS–T angle. Method: In this study, 200 patients who were prescribed flecainide therapy due to atrial or ventricular arrhythmias were included. Prior to the initiation of flecainide treatment, all patients underwent a 12-lead electrocardiogram (ECG) in which heart rate (HR), PR and QRS durations, QT, QTc, JT, Tp–Te intervals and the frontal plane QRS–T angle were measured. At the 1-month follow-up, patients underwent repeat ECG recording and were evaluated for both cardiac and non-cardiac side effects of flecainide. The same ECG parameters were measured again using the follow-up recordings. Changes in ECG parameters between the baseline and 1-month post-treatment were analyzed. Results: Following flecainide administration, the drug was discontinued in 18 patients (9%) due to adverse effects (11 cases of cardiac and seven cases of non-cardiac). HR significantly decreased (78 ± 22 bpm to 74 ± 15 bpm and p < 0.05). PR interval and QRS duration significantly increased (148 ± 23 ms to 156 ± 9 ms and 89 ± 17 ms to 99 ± 19 ms, respectively p < 0.05 for each). Additionally, JT interval (326 ± 27 ms vs. 334 ± 6 ms), QT interval (416 ± 24 ms vs. 434 ± 24 ms), QTc interval (431 ± 24 vs. 447 ± 25 ms) and Tp–Te interval (84 ± 17 vs. 87 ± 18 ms) all showed statistically significant increases after flecainide treatment (p < 0.05 for-each). However, no significant change was observed in the frontal QRS–T angle. Discussion: In patients receiving flecainide therapy for atrial and ventricular arrhythmias, prolongation was observed in atrioventricular conduction, ventricular depolarization and repolarization parameters as measured by ECG. However, no significant change was detected in the frontal QRS–T angle.
- 4 September 2020
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 37 (1) , 207-213
Are there any subclinical myocardial dysfunctions in subjects with aortic valve sclerosis? A 3D-speckle tracking echocardiography study
Aortic valve sclerosis (AVS) is defined as calcified and thickened aortic leaflets without restriction of leaflet motion. We have not found any studies that previously assessed the effect of AVS on myocardial functions with three dimensional-speckle tracking echocardiography (3D-STE). Therefore, we aimed to identify any early changes in left atrial (LA) myocardial dynamics and/or left ventricular (LV) systolic functions in patients with AVS using 3D-STE. Seventy-five patients with AVS and 80 age- and gender-matched controls were enrolled into the study. The baseline clinical characteristics of the study patients were recorded. Conventional 2D echocardiographic and 3D-STE analyses were performed. The LV-global longitudinal strain (LV-GLS) and LV-global circumferential strain (LV-GCS) were significantly decreased in the AVS (+) group than in the control group (p < 0.001 and p = 0.013, respectively). In multivariate logistic regression analysis; LV-GLS (p < 0.001, odds ratio (OR) = 3.16, 95% confidence interval (CI) 1.42–5.63) and Triglyceride (TG) (p = 0.033, OR = 1.29, 95% CI 1.11–1.72) were found to be independent predictors of AVS. ROC analysis was performed to find out the ideal LV-GLS cut-off value for predicting the AVS. A LV-GLS value of > − 18 has 85.8% sensitivity, 67.5% specificity for the prediction of the AVS. Our results support that subjects with AVS may have subclinical LV deformation abnormalities even though they have not LV pressure overload. According to our findings, patients with AVS should be investigated in terms of atherosclerotic risk factors, their dysmetabolic status should be evaluated and closely followed up for their progression to calcific aortic stenosis.
- 4 September 2020
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 37 (1) , 207-213
Are there any subclinical myocardial dysfunctions in subjects with aortic valve sclerosis? A 3D-speckle tracking echocardiography study
Aortic valve sclerosis (AVS) is defined as calcified and thickened aortic leaflets without restriction of leaflet motion. We have not found any studies that previously assessed the effect of AVS on myocardial functions with three dimensional-speckle tracking echocardiography (3D-STE). Therefore, we aimed to identify any early changes in left atrial (LA) myocardial dynamics and/or left ventricular (LV) systolic functions in patients with AVS using 3D-STE. Seventy-five patients with AVS and 80 age- and gender-matched controls were enrolled into the study. The baseline clinical characteristics of the study patients were recorded. Conventional 2D echocardiographic and 3D-STE analyses were performed. The LV-global longitudinal strain (LV-GLS) and LV-global circumferential strain (LV-GCS) were significantly decreased in the AVS (+) group than in the control group (p < 0.001 and p = 0.013, respectively). In multivariate logistic regression analysis; LV-GLS (p < 0.001, odds ratio (OR) = 3.16, 95% confidence interval (CI) 1.42–5.63) and Triglyceride (TG) (p = 0.033, OR = 1.29, 95% CI 1.11–1.72) were found to be independent predictors of AVS. ROC analysis was performed to find out the ideal LV-GLS cut-off value for predicting the AVS. A LV-GLS value of > − 18 has 85.8% sensitivity, 67.5% specificity for the prediction of the AVS. Our results support that subjects with AVS may have subclinical LV deformation abnormalities even though they have not LV pressure overload. According to our findings, patients with AVS should be investigated in terms of atherosclerotic risk factors, their dysmetabolic status should be evaluated and closely followed up for their progression to calcific aortic stenosis.
- 1 January 2012
- Vol. 70 (6) , 646-7
Myocardial bridging of the left anterior descending coronary artery and right coronary artery in a patient with mitral valve stenosis.
Myocardial bridging is defined as the intramural course of a major epicardial coronary artery, and is mostly confined to the left ventricle and the left anterior descending coronary artery (LAD). Although it is considered to be a benign anomaly, it can lead to such complications as acute myocardial infarction, ventricular tachycardia, syncope, atrioventricular block and sudden cardiac death. Isolated myocardial bridging of the right coronary artery (RCA) and left circumflex artery have been reported in the literature In our case, myocardial bridging was observed in both the LAD and the RCA in a patient with mitral valve stenosis.
- 1 January 2012
- Vol. 70 (6) , 646-7
Myocardial bridging of the left anterior descending coronary artery and right coronary artery in a patient with mitral valve stenosis.
Myocardial bridging is defined as the intramural course of a major epicardial coronary artery, and is mostly confined to the left ventricle and the left anterior descending coronary artery (LAD). Although it is considered to be a benign anomaly, it can lead to such complications as acute myocardial infarction, ventricular tachycardia, syncope, atrioventricular block and sudden cardiac death. Isolated myocardial bridging of the right coronary artery (RCA) and left circumflex artery have been reported in the literature In our case, myocardial bridging was observed in both the LAD and the RCA in a patient with mitral valve stenosis.